No Data
No Data
No Data
No Data
No Data
Tudor Investment Corp Et Al Makes New $169,000 Investment in Metacrine, Inc. (NASDAQ:MTCR)
Tudor Investment Corp Et Al bought a new stake in Metacrine, Inc. (NASDAQ:MTCR – Get Rating) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commissi
Defense WorldMar 11, 2023 05:51 ET
Nasdaq to Delist Shares of Waitr and Calithera Biosciences, Among Others
Seeking AlphaMar 1, 2023 18:26 ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersHTG Molecular Diagnostics (NASDAQ:HTGM) shares moved upwards by 33.0% to $6.01 during Wednesday's after-market session. This security traded at a volume of 323.6K shares come close, making up 2
Benzinga Real-time NewsFeb 1, 2023 16:32 ET
Insider Selling: Metacrine, Inc. (NASDAQ:MTCR) CEO Sells $156,048.05 in Stock
Metacrine, Inc. (NASDAQ:MTCR – Get Rating) CEO Preston Klassen sold 380,605 shares of the company's stock in a transaction that occurred on Thursday, January 26th. The stock was sold at an average pr
Financial News LiveJan 30, 2023 04:51 ET
Preston Klassen Sells 380,605 Shares of Metacrine, Inc. (NASDAQ:MTCR) Stock
Metacrine, Inc. (NASDAQ:MTCR – Get Rating) CEO Preston Klassen sold 380,605 shares of the firm's stock in a transaction on Thursday, January 26th. The stock was sold at an average price of $0.41, for
Defense WorldJan 29, 2023 05:51 ET
Insider Selling: Metacrine, Inc. (NASDAQ:MTCR) Insider Sells 107,054 Shares of Stock
Metacrine, Inc. (NASDAQ:MTCR – Get Rating) insider Michael York sold 107,054 shares of Metacrine stock in a transaction on Thursday, January 26th. The stock was sold at an average price of $0.41, for
kopsourceJan 27, 2023 18:35 ET
NightCrawler999 : It is 52w low at most historical month lol
No Data
No Data
Mang1281 : 这是老千股,快跑